A gene fusion system for generating antibodies against short peptides
- PMID: 3692175
- DOI: 10.1016/0378-1119(87)90032-1
A gene fusion system for generating antibodies against short peptides
Abstract
A novel method to obtain specific antibodies against short peptides is described, involving synthesis of the corresponding oligodeoxynucleotides followed by cloning into a new set of fusion vectors, pEZZ8 and pEZZ18, based on two synthetic IgG-binding domains (ZZ) of Staphylococcus aureus protein A. The soluble gene fusion product thus obtained, can be collected from the culture medium of Escherichia coli and rapidly recovered in a one-step procedure by IgG affinity chromatography. The system was used to express a fusion protein consisting of the two Z fragments and the C-terminal part [amino acids (aa) 57-70] of human insulin-like growth factor I (IGF-I). This 16-kDa protein was purified by affinity chromatography on IgG Sepharose and antibodies were raised in rabbits. The fusion protein elicited peptide-specific antibodies, as measured by solid-phase radioimmuno assay and Western blotting, reactive with both synthetic C-terminal peptide and the native human IGF-I protein. The results suggests that the gene fusion system can be used for efficient antibody production against short peptides encoded by synthetic oligodeoxynucleotides.
Similar articles
-
Production of specific antibodies against protein A fusion proteins.EMBO J. 1986 Sep;5(9):2393-8. doi: 10.1002/j.1460-2075.1986.tb04509.x. EMBO J. 1986. PMID: 3096719 Free PMC article.
-
Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification.Biochemistry. 1987 Aug 25;26(17):5239-44. doi: 10.1021/bi00391a005. Biochemistry. 1987. PMID: 3676250
-
Protein engineering to optimize recombinant protein purification.Biochem Soc Trans. 1988 Apr;16(2):111-2. doi: 10.1042/bst0160111. Biochem Soc Trans. 1988. PMID: 3163658
-
Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.DNA Cell Biol. 1997 Jul;16(7):883-92. doi: 10.1089/dna.1997.16.883. DNA Cell Biol. 1997. PMID: 9260931
-
Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines.Adv Exp Med Biol. 1989;251:215-8. doi: 10.1007/978-1-4757-2046-4_21. Adv Exp Med Biol. 1989. PMID: 2481962 Review.
Cited by
-
Analyzing In Vivo Metabolite-Protein Interactions By Large-Scale Systematic Analyses.Curr Protoc Chem Biol. 2011;3(4):181-196. doi: 10.1002/9780470559277.ch110193. Epub 2011 Dec 1. Curr Protoc Chem Biol. 2011. PMID: 22846927 Free PMC article.
-
Biologically active and amidated cecropin produced in a baculovirus expression system from a fusion construct containing the antibody-binding part of protein A.Biochem J. 1991 Nov 15;280 ( Pt 1)(Pt 1):219-24. doi: 10.1042/bj2800219. Biochem J. 1991. PMID: 1720614 Free PMC article.
-
Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.J Biol Chem. 2010 Sep 24;285(39):30170-80. doi: 10.1074/jbc.M110.137562. Epub 2010 Jul 27. J Biol Chem. 2010. PMID: 20663884 Free PMC article.
-
The use of recombinant fusion proteases in the affinity purification of recombinant proteins.Mol Biotechnol. 1999 Oct;12(3):269-74. doi: 10.1385/MB:12:3:269. Mol Biotechnol. 1999. PMID: 10631683
-
Recombinant Escherichia coli strain produces a ZZ domain displaying biopolyester granules suitable for immunoglobulin G purification.Appl Environ Microbiol. 2006 Nov;72(11):7394-7. doi: 10.1128/AEM.01014-06. Epub 2006 Aug 25. Appl Environ Microbiol. 2006. PMID: 16936052 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials